Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperbaric Oxygen Therapy Improve Acute Graft-Versus-Host Disease in Patients Underwent Allogeneic Hematopoietic Stem Cell Transplantation

NCT05078073 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.

NCT NCT05078073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05078073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperbaric Oxygen Therapy Improve Acute Graft-Versus-Host Disease in Patients Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Shandong Provincial Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 10, 2021
Completion date
August 10, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-graft-versus-host disease, hyperbaric oxygen therapy